.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Citi
Chinese Patent Office
Julphar
McKesson
Merck
US Department of Justice
Cipla
Fish and Richardson
Cerilliant

Generated: September 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Treatment of inflammation and allergy
Abstract:The present invention provides a new medical use for the phenethanolamine compound 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction.
Inventor(s): Johnson; Malcolm (Orwell, GB2), Whelan; Clifford J. (Buntingford, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:07/799,001
Patent Claims: 1. A method of treatment of a mammal, including man, suffering from the late asthmatic reaction which comprises administering an effective amount of 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol or a physiologically acceptable salt or solvate thereof.

2. A method of treatment of a mammal, including man, suffering from late-phase asthma which comprises administering an effective amount of 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]-methyl]-1,3-benzenedimethanol or a physiologically acceptable salt or solvate thereof.

3. A method of treatment according to any one of claims 1 or 2 which comprises administering an effective amount of 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol, 1-hydroxy-2-naphthalene-carboxylate salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Farmers Insurance
Accenture
Harvard Business School
Boehringer Ingelheim
Chubb
US Department of Justice
Moodys
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot